CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study) A Survey on Coronary Atherosclerotic Plaque Tissue Characterization in Intravascular Optical Coherence Tomography Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study Outcomes of procedural complications in transfemoral transcatheter aortic valve replacement Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI Definition and Management of Segmental Pulmonary Hypertension Streamlined reverse wire technique for the treatment of complex bifurcated lesions
|<<... 135 136 137 138 139 140 141 ...>>|

Original Research2008 Sep 2;118(10):1011-20.

JOURNAL：Circulation. Article Link

Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction

Kwong RY, Sattar H, Wu H et al. Keywords: unrecognized myocardial scar; myocardial infarction; cardiac magnetic resonance; incidence

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top